Nomura Research In (NRILY) Cut to “Hold” at Zacks Investment Research

Nomura Research In (OTCMKTS:NRILY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Saturday.

According to Zacks, “Nomura Research Institute, Ltd. provides research, business consulting and systems services. Its operating segment consists of Consulting, Financial Information Technology Solutions, Industrial IT Solutions, IT Platform Services and Others. Consulting segment provides management and systems consulting services. Financial IT Solutions segment offers IT solutions for securities, asset management, banking, and insurance sectors. Industrial IT Solutions segment deals with IT solutions and infrastructure services for distribution, manufacturing, service and healthcare industries, as well as for governments and other public agencies. IT Platform Services segment handles system management and advanced information technology solutions. It also conducts research for the development of new business operations and new products related to IT solutions. Others segment administers systems development and operation services on other businesses. Nomura Research Institute, Ltd. is headquartered in Tokyo, Japan. “

How to Become a New Pot Stock Millionaire

Shares of Nomura Research In stock opened at $11.45 on Friday. Nomura Research In has a one year low of $8.59 and a one year high of $11.78. The stock has a market capitalization of $10,937.22, a P/E ratio of 27.26, a PEG ratio of 2.65 and a beta of 2.02. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.96 and a quick ratio of 1.96.

COPYRIGHT VIOLATION NOTICE: This news story was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another site, it was illegally stolen and reposted in violation of United States and international copyright laws. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3337425/nomura-research-in-nrily-cut-to-hold-at-zacks-investment-research.html.

About Nomura Research In

Nomura Research Institute, Ltd. engages in consulting, financial information technology (IT) solutions, industrial IT solutions, and IT platform services businesses primarily in Japan. The Consulting segment offers management consulting services to develop business strategies, reengineer operations, support government/public agencies, and implement administrative reforms; and systems consulting services to enhance the use of IT, including IT strategic development, business reengineering planning and execution support, standardized architecture implementation, global cross-functional IT governance, and others.

Get a free copy of the Zacks research report on Nomura Research In (NRILY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nomura Research In Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nomura Research In and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

BidaskClub Downgrades Merit Medical Systems  to Hold
BidaskClub Downgrades Merit Medical Systems to Hold
Keryx Biopharmaceuticals  Upgraded at BidaskClub
Keryx Biopharmaceuticals Upgraded at BidaskClub
Alphabet  Upgraded to Buy by BidaskClub
Alphabet Upgraded to Buy by BidaskClub
Durect  Downgraded by BidaskClub
Durect Downgraded by BidaskClub
Calumet Specialty Products Partners  Stock Rating Upgraded by BidaskClub
Calumet Specialty Products Partners Stock Rating Upgraded by BidaskClub
Yext  Insider Sells $162,625.00 in Stock
Yext Insider Sells $162,625.00 in Stock


© 2006-2018 Ticker Report. Google+.